BRIEF published on 06/18/2025 at 07:05, 1 year 4 months ago PHAXIAM Therapeutics suspends trading of its shares Euronext Paris Innovative Treatments PHAXIAM Suspension Of Quotation Delisting Securities
PRESS RELEASE published on 06/18/2025 at 07:00, 1 year 4 months ago Inside Information / Other news releases PHAXIAM Therapeutics suspends trading shares for delisting on Euronext Paris market. No reimbursement to shareholders. Company focuses on innovative phage-based treatments for resistant bacterial infections Trading Delisting Suspension PHAXIAM Therapeutics Phage-based Treatments
BRIEF published on 06/05/2025 at 07:05, 1 year 5 months ago PHAXIAM Therapeutics Facing Potential Liquidation Amid Court Hearing Postponement Biopharmaceuticals Judicial Liquidation Court Hearing PHAXIAM Therapeutics Euronext Delisting
PRESS RELEASE published on 06/05/2025 at 07:00, 1 year 5 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces new postponement of Offer Review Hearing by Lyon Commercial Court to June 11, 2025. Company to request delisting from Euronext Euronext Delisting Postponement PHAXIAM Therapeutics Lyon Commercial Court
BRIEF published on 03/14/2025 at 17:50, 1 year 7 months ago PHAXIAM Therapeutics seeks buyer in receivership Euronext Paris PHAXIAM Therapeutics Judicial Recovery Looking For A Buyer Extension Of Procedure
PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 7 months ago Inside Information / Other news releases PHAXIAM Therapeutics launches bidding process to find buyers amid receivership, trading of shares to resume on Euronext Paris. Court decides on procedure extension on April 30, 2025 Euronext Paris Receivership PHAXIAM Therapeutics Court Decision Bidding Process
BRIEF published on 03/06/2025 at 18:01, 1 year 8 months ago PHAXIAM Therapeutics Enters Receivership and Delays Financial Results Trading Suspension Financial Results Delay PHAXIAM Receivership Biotech Challenges Court-appointed Administrator
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 8 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces the opening of a receivership procedure and postponement of its 2024 financial results publication. The company continues operations under observation period Financial Results Biopharmaceutical Company PHAXIAM Therapeutics Receivership Procedure Phage-based Treatments
BRIEF published on 03/06/2025 at 11:45, 1 year 8 months ago Suspension of the Listing of PHAXIAM Therapeutics Euronext Paris Biopharmaceutical PHAXIAM Therapeutics Suspension Of Quotation Resistant Infections
BRIEF published on 12/30/2024 at 17:50, 1 year 10 months ago PHAXIAM Therapeutics: Promising results from the PhagoDAIR pilot study Infection Control PHAXIAM Therapeutics Phase II GLORIA PhagoDAIR Study Anti-S. Aureus Phages
Published on 11/11/2026 at 14:00, 23 minutes ago PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 23 minutes ago NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Published on 11/11/2026 at 13:15, 1 hour 8 minutes ago Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
Published on 11/11/2026 at 13:00, 1 hour 23 minutes ago NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
Published on 11/11/2026 at 13:00, 1 hour 23 minutes ago Irving Resources Reports on Drilling in Yamagano Mining Right at the Yamagano Joint Venture, Kyushu, Japan
Published on 11/11/2026 at 13:13, 1 hour 10 minutes ago Elmos Semiconductor SE and AGIBOT showcase Humanoid Robotics at electronica 2026
Published on 11/11/2026 at 13:05, 1 hour 18 minutes ago SwitchBot Introduces Curtain Track 4 for Smarter Curtains with Less Upkeep
Published on 11/11/2026 at 12:05, 2 hours 18 minutes ago H.I.G. Capital Signs Definitive Agreement to Acquire Majority Stake in go asia
Published on 11/11/2026 at 12:05, 2 hours 18 minutes ago EYKON brings digital revenue metering into the digital substation
Published on 11/11/2026 at 11:46, 2 hours 37 minutes ago ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/10/2026 at 17:31, 20 hours 51 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 1 day ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 1 day 3 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 1 day 7 hours ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 19 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
